The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma
Open accessAbstract
Purpose: Neoadjuvant pemetrexed plus cisplatin was administered, followed by extrapleural pneumonectomy (EPP) and hemithoracic radiation (RT), to assess the feasibility and efficacy of trimodality therapy in stage I to III malignant pleural mesothelioma. Patients and Methods: Requirements included stage T1-3 N0-2 disease, no prior surgical resection, adequate organ function (including predicted postoperative forced expiratory volume in 1 second ≥ 35%), and performance status 0 to 1. Patients received pemetrexed 500 mg/m 2 plus cisplatin 75 mg/m 2 for four cycles. Patients without disease progression underwent EPP followed by RT (54 Gy). The primary end point was pathologic complete response (pCR) rate. Results: Seventy-seven patients received chemotherapy. All four cycles were administered to 83% of patients. The radiologic response rate was 32.5% (95% CI, 22.2 to 44.1). Fifty-seven patients proceeded to EPP, which was completed in 54 patients. Three pCRs were observed (5% of EPP). Forty of 44 patients completed irradiation. Median survival in the overall population was 16.8 months (95% CI, 13.6 to 23.2 months; censorship, 33.8%). Patients completing all therapy had a median survival of 29.1 months and a 2-year survival rate of 61.2%. Radiologic response of complete or partial response was associated with a median survival of 26.0 months compared with 13.9 months for patients with stable disease or progressive disease (P = .05). Conclusion: This multicenter trial showed that trimodality therapy with neoadjuvant pemetrexed plus cisplatin is feasible with a reasonable long-term survival rate, particularly for patients who completed all therapy. Radiologic response to chemotherapy, but not sex, histology, disease stage, or nodal status, was associated with improved survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Cox, J. D., Stetz, J., & Pajak, T. F. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00060-c · Cited by 4,792
Vogelzang, N. J., Rusthoven, J. J., Symanowski, J., Denham, C., Kaukel, E., Ruffie, P., Gatzemeier, U., Boyer, M., Emri, S., Manegold, C., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.136 · Cited by 3,060
Self-citationAmerican Joint Committee On Cancer (2010) · Springer eBooks · doi:10.1007/978-0-387-88443-1 · Cited by 1,386
Sugarbaker, D. J., Flores, R. M., Jaklitsch, M. T., Richards, W. G., Strauss, G. M., Corson, J. M., DeCamp, M. M., Swanson, S. J., Bueno, R., Lukanich, J. M., et al. (1999) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(99)70469-1 · Cited by 985
Self-citationThe European mesothelioma epidemic
Peto, J., Decarli, A., Vecchia, C. L., Levi, F., & Negri, E. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690105 · Cited by 891
Modified RECIST criteria for assessment of response in malignant pleural mesothelioma
Byrne, M. J., & Nowak, A. K. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh059 · Cited by 645
Flores, R. M., Pass, H. I., Seshan, V. E., Dycoco, J., Zakowski, M., Carbone, M., Bains, M. S., & Rusch, V. W. (2008) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.10.054 · Cited by 617
Self-citationMesothelin-family proteins and diagnosis of mesothelioma
Robinson, B. W., Creaney, J., Lake, R., Nowak, A., Musk, A. W., de Klerk, N., Winzell, P., Hellstrom, K. E., & Hellstrom, I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14794-0 · Cited by 534
Rusch, V. W., Rosenzweig, K., Venkatraman, E., Leon, L., Raben, A., Harrison, L., Bains, M. S., Downey, R. J., & Ginsberg, R. J. (2001) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.116560 · Cited by 493
Self-citationAsbestos Exposure, Pleural Mesothelioma, and Serum Osteopontin Levels
Pass, H. I., Lott, D., Lonardo, F., Harbut, M., Liu, Z., Tang, N., Carbone, M., Webb, C., & Wali, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051185 · Cited by 357
Self-citationFatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma
Allen, A. M., Czerminska, M., Jänne, P. A., Sugarbaker, D. J., Bueno, R., Harris, J. R., Court, L., & Baldini, E. H. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.03.012 · Cited by 351
Self-citationCisplatin and Gemcitabine Treatment for Malignant Mesothelioma: A Phase II Study
Byrne, M. J., Davidson, J. A., Musk, A. W., Dewar, J., van Hazel, G., Buck, M., de Klerk, N. H., & Robinson, B. W. S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.25 · Cited by 334
Weder, W., Stahel, R. A., Bernhard, J., Bodis, S., Vogt, P., Ballabeni, P., Lardinois, D., Betticher, D., Schmid, R., Stupp, R., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm093 · Cited by 320
Analysis of Current Trends in United States Mesothelioma Incidence
Price, B. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009093 · Cited by 278
Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically
Rusch, V. W., & Venkatraman, E. S. (1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)01038-3 · Cited by 250
Self-citationNeoadjuvant Chemotherapy Followed by Extrapleural Pneumonectomy in Malignant Pleural Mesothelioma
Weder, W., Kestenholz, P., Taverna, C., Bodis, S., Lardinois, D., Jerman, M., & Stahel, R. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.071 · Cited by 241
Induction chemotherapy before surgery for early-stage lung cancer: A novel approach
Pisters, K. M. W., Ginsberg, R. J., Giroux, D. J., Putnam, J. B., Kris, M. G., Johnson, D. H., Roberts, J. R., Mault, J., Crowley, J. J., & Bunn, P. A. (2000) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(00)70120-6 · Cited by 235
Self-citationFlores, R. M., Zakowski, M., Venkatraman, E., Krug, L., Rosenzweig, K., Dycoco, J., Lee, C., Yeoh, C., Bains, M., & Rusch, V. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31815608d9 · Cited by 229
Self-citationThe importance of surgical staging in the treatment of malignant pleural mesothelioma
Rusch, V. W., & Venkatraman, E. (1996) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70342-2 · Cited by 205
Self-citationFlores, R. M., Krug, L. M., Rosenzweig, K. E., Venkatraman, E., Vincent, A., Heelan, R., Akhurst, T., & Rusch, V. W. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31583-5 · Cited by 167
Self-citationSurgically debulked malignant pleural mesothelioma: Results and prognostic factors
Pass, H. I., Kranda, K. C., TEMECK, B. K., Feuerstein, I. R., & Steinberg, S. M. (1997) · Annals of Surgical Oncology · doi:10.1007/bf02306613 · Cited by 157
Self-citationTranscriptome sequencing of malignant pleural mesothelioma tumors
Sugarbaker, D. J., Richards, W. G., Gordon, G. J., Dong, L., De Rienzo, A., Maulik, G., Glickman, J. N., Chirieac, L. R., Hartman, M.-L., Taillon, B. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712399105 · Cited by 155
Self-citationRea, F., Marulli, G., Bortolotti, L., Breda, C., Favaretto, A. G., Loreggian, L., & Sartori, F. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.02.004 · Cited by 144
Surgical Treatment of Malignant Pleural Mesothelioma*
van Ruth, S., Baas, P., & Zoetmulder, F. A. N. (2003) · CHEST Journal · doi:10.1378/chest.123.2.551 · Cited by 108
de Perrot, M. E., Uy, K. F. L., Anraku, M., Tsao, M., Darling, G. E., Waddell, T. K., Pierre, A. F., Bezjak, A., Keshavjee, S. H., & Johnston, M. R. (2006) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2006.06.044 · Cited by 80
Trimodality Treatment of Malignant Pleural Mesothelioma
Batırel, H. F., Metintaş, M., Çağlar, H. B., Yıldızeli, B., Laçin, T., Bostancı, K., Akgül, A. G., Evman, S., & Yüksel, M. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31816fca1b · Cited by 78
Stewart, D. J., Martin-Ucar, A. E., Pilling, J. E., et al. (2004) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2004.01.034 · Cited by 65
Epidemiology, biologic behavior, and natural history of mesothelioma
Zellos, L. S., & Christiani, D. C. (2004) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2004.06.011 · Cited by 64
Patterns of failure following surgical resection for malignant pleural mesothelioma
Janne, P. A., & Baldini, E. H. (2004) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2004.06.006 · Cited by 62
External beam radiation therapy for the treatment of pleural mesothelioma
Baldini, E. H. (2004) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/s1547-4127(04)00108-2 · Cited by 46
Cited by
Treasure, T., Lang-Lazdunski, L., Waller, D., Bliss, J. M., Tan, C., Entwisle, J., Snee, M., O'Brien, M., Thomas, G., Senan, S., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70149-8 · Cited by 708
Malignant Pleural Mesothelioma
Tsao, A. S., Wistuba, I., Roth, J. A., & Kindler, H. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8523 · Cited by 481
Self-citationKindler, H. L., Ismaila, N., Armato, S. G., Bueno, R., Hesdorffer, M., Jahan, T., Jones, C. M., Miettinen, M., Pass, H., Rimner, A., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.6394 · Cited by 420
Self-citationBaas, P., Fennell, D., Kerr, K. M., Van Schil, P. E., Haas, R. L., & Peters, S. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv199 · Cited by 417
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
Bibby, A. C., Tsim, S., Kanellakis, N., Ball, H., Talbot, D. C., Blyth, K. G., Maskell, N. A., & Psallidas, I. (2016) · European Respiratory Review · doi:10.1183/16000617.0063-2016 · Cited by 316
Metadata
- Authors
- Krug, L. M., Pass, H. I., Rusch, V. W., Kindler, H. L., Sugarbaker, D. J., Rosenzweig, K. E., Flores, R., Friedberg, J. S., Pisters, K., Monberg, M., Obasaju, C. K., & Vogelzang, N. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-06-20
- Volume
- 27
- Issue
- 18
- Pages
- 3007-3013
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2097851464
- Cited by
- 467
- References
- 32
- FWCI
- 33.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.